Novel combination of epirubicin, bleomycin, vinblastine and prednisone (EBVP II) before radical radiotherapy in localized stages (I-IIIA) of Hodgkin's disease
- 1 July 1991
- journal article
- clinical trial
- Published by Springer Nature in Zeitschrift für Krebsforschung und Klinische Onkologie
- Vol. 117 (4) , 377-380
- https://doi.org/10.1007/bf01630723
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Combination of ABVD and radiotherapy in early stages of Hodgkin's disease: analysis of a series of 94 patientsRadiotherapy and Oncology, 1990
- Influence of dose intensity and density on therapeutic and toxic effects in Hodgkin's diseaseBritish Journal of Cancer, 1989
- Hodgkin's disease: challenges for the future.1989
- Quality of life during and after treatment of Hodgkin's disease.1989
- Quality of Life During and After Treatment of Hodgkin’s DiseasePublished by Springer Nature ,1989
- EBVP-II (EPIRUBICINE, BLEOMYCINE, VINBLASTINE, PREDNISONE) CHEMOTHERAPY BEFORE RADIOTHERAPY IN LOCALIZED HODGKINS-DISEASE - PHASE-II TRIAL1988
- The chemotherapy of lymphomas: looking back, moving forward--the Richard and Hinda Rosenthal Foundation award lecture.1987
- Adriamycin versus epirubicin in advanced soft tissue sarcomas. A randomized phase II/phase III study of the EORTC soft tissue and bone sarcoma groupEuropean Journal of Cancer and Clinical Oncology, 1987
- EBVP (EPIRUBICINE, BLEOMYCINE, VINBLASTINE, PREDNISONE) CHEMOTHERAPY BEFORE RADIOTHERAPY IN LOCALIZED HODGKINS-DISEASE - PHASE-II TRIAL1987
- Alternating Non-Cross-Resistant Combination Chemotherapy or MOPP in Stage IV Hodgkin's DiseaseAnnals of Internal Medicine, 1986